1. Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
- Author
-
Kevin Zhai, Olga Golunitschaja, Marek Samec, Frank A. Giordano, Dietrich Büsselberg, Peter Kubatka, Lenka Koklesova, and Alena Liskova
- Subjects
Mitochondrial DNA ,Coronavirus disease 2019 (COVID-19) ,Patient stratification ,Mitigating measures ,Context (language use) ,Injury ,Biomarker panel ,Review ,Outcomes ,Energy imbalance ,Bioinformatics ,Vicious circle ,Individualised patient profiling ,Suboptimal health ,Origin ,Multifactorial disease ,Drug Discovery ,medicine ,Mechanisms ,Predictive preventive personalised medicine (PPPM/3PM) ,Molecular patterns ,Cost efficacy ,Neurodegeneration ,Cancer ,Multi-modal diagnostics ,Liquid biopsy ,business.industry ,Biochemistry (medical) ,COVID-19 ,ROS ,Glaucoma ,medicine.disease ,Vasospasm ,Cardiovascular disease ,Health policy ,Medical services ,Ageing ,Mitochondrial impairment ,Oxidative stress ,Reversible damage ,Alzheimer ,Aetiopathology multi-organ dysfunction ,Complementary medicine ,business ,Repair - Abstract
Mitochondrial injury plays a key role in the aetiopathology of multifactorial diseases exhibiting a “vicious circle” characteristic for pathomechanisms of the mitochondrial and multi-organ damage frequently developed in a reciprocal manner. Although the origin of the damage is common (uncontrolled ROS release, diminished energy production and extensive oxidative stress to life-important biomolecules such as mtDNA and chrDNA), individual outcomes differ significantly representing a spectrum of associated pathologies including but not restricted to neurodegeneration, cardiovascular diseases and cancers. Contextually, the role of predictive, preventive and personalised (PPPM/3P) medicine is to introduce predictive analytical approaches which allow for distinguishing between individual outcomes under circumstance of mitochondrial impairments followed by cost-effective targeted prevention and personalisation of medical services. Current article considers innovative concepts and analytical instruments to advance management of mitochondriopathies and associated pathologies.
- Published
- 2021